Clinical Trial Update: A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety [Phase 3]

View source ↗

Summary

Praxis Precision Medicines is conducting a Phase 3 trial of Elsunersen in children with SCN2A-related epileptic encephalopathy to assess efficacy and safety; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epileptic Encephalopathy
• Scn2a-related Epileptic Encephalopathy

Drugs mentioned

• Elsunersen

Snippet

Sponsor: Praxis Precision Medicines | Conditions: Epileptic Encephalopathy, SCN2A Encephalopathy | Phase 3 | Status: RECRUITING